Avalo Therapeutics Inc (AVTX) — Capital Reinvestment Ratio
Latest as of September 2022:
0.01x
Avalo Therapeutics Inc (AVTX) has a Capital Reinvestment Ratio of 0.01x as of September 2022, meaning it reinvests 0% of its operating cash flow ($5.73 Million) in capital expenditures ($39.00K). See Avalo Therapeutics Inc free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.01x
Capex / Operating Cash Flow
Operating Cash Flow
$5.73 Million
USD
Capital Expenditures
$39.00K
USD
Data as of
Sep 2022
Most recent filing
Avalo Therapeutics Inc Capital Reinvestment Ratio (2017–2017)
This chart tracks Avalo Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Avalo Therapeutics Inc (2017–2017)
Year-by-year Capital Reinvestment Ratio for Avalo Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see market value of Avalo Therapeutics Inc.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 0.00x | $12.52 Million | $23.32K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow